Background: Regulatory mechanisms of adult neurogenesis are not clearly defined. Results: Extracellular signal-Regulated Kinase 5 is specifically expressed in adult neurogenic regions, and is critical for adult hippocampal neurogenesis. Conclusion: ERK5 signaling regulates adult hippocampal neurogenesis, a process that may be mediated through Neurogenin 2. Significance: Identification of signaling pathways involved in adult neurogenesis contributes toward delineating the molecular mechanisms regulating adult neurogenesis.
SUMMARY
Recent studies have led to the exciting idea that adult-born neurons in the dentate gyrus of the hippocampus may play a role in hippocampus-dependent memory formation. However, signaling mechanisms that regulate adult hippocampal neurogenesis are not well defined. Here we report that Extracellular signal-Regulated Kinase 5 (ERK5), a member of the mitogen-activated protein kinase family, is selectively expressed in the neurogenic regions of the adult mouse brain. We present evidence that shRNA suppression of ERK5 in adult hippocampal neural stem/progenitor cells (aNPCs) reduces the number of neurons while increasing the number of cells expressing markers for stem/progenitor cells or proliferation. Furthermore, shERK5 attenuates both transcription and neuronal differentiation mediated by Neurogenin 2, a transcription factor expressed in adult hippocampal neural progenitor cells. By contrast, ectopic activation of endogenous ERK5 signaling via expression of constitutive active MEK5, an upstream activating kinase for ERK5, promotes neurogenesis in cultured aNPCs and in the dentate gyrus of the mouse brain. Moreover, neurotrophins including NT3 activate ERK5 and stimulate neuronal differentiation in aNPCs in an ERK5-dependent manner. Finally, inducible and conditional deletion of ERK5 specifically in the neurogenic regions of the adult mouse brain delays the normal progression of neuronal differentiation and attenuates adult neurogenesis in vivo. These data suggest ERK5 signaling as a critical regulator of adult hippocampal neurogenesis.
Adult neurogenesis occurs in the dentate gyrus of mammalian brains, including the human brain (1) (2) (3) (4) . Adult-born neurons functionally integrate into the hippocampal circuitry (5) (6) (7) (8) (9) (10) (11) , suggesting that adult neurogenesis may contribute to neuroplasticity. This idea is supported by the observation that hippocampus-dependent, but not hippocampus-independent learning increases the number of adult-born neurons in the dentate gyrus (12) (13) (14) . Despite the interest in the physiological roles of adult-born neurons, mechanisms regulating adult neurogenesis have not been fully elucidated.
ERK5 is a member of the mitogen-activated protein (MAP) kinase family that includes ERK1/2, p38, and JNK (15, 16) . It is specifically phosphorylated and activated by MEK5 (15, 17) . MEK5 is specific for ERK5 and does not phosphorylate ERK1/2, JNK or p38 even when overexpressed (15, 17) . ERK5 is activated by neurotrophins (NT) through MEK5, which promotes the survival of newborn neurons during embryonic development (18) (19) (20) (21) (22) (23) . Furthermore, ERK5 specifies cortical stem/progenitor cells toward a neuronal lineage during development by phosphorylating and modulating the activity of neurogenin (Neurog) 1 (24, 25) . ERK5 expression in the brain is developmentally regulated; it is high during early embryonic development but declines postnatally as the brain matures (21) . Interestingly, although there is very little ERK5 expression throughout the adult brain (26) , upon closer examination we report here that ERK5 is prominently expressed in the two adult neurogenic regions: the subgranular zone (SGZ) of the dentate gyrus and the subventricular zone (SVZ) along the lateral ventricles. This unique pattern of expression suggests a fundamentally important role for ERK5 in regulating adult neurogenesis.
In this study, we have characterized the cell types expressing ERK5 along the SGZ of the dentate gyrus. To investigate a role for ERK5 in the regulation of adult neurogenesis, we utilized RNAi and transgenic mouse technologies to inhibit ERK5 expression as well as retroviral expression of a constitutive active (ca) MEK5 to stimulate ERK5 both in vitro and in vivo. Our data suggest a critical role for ERK5 in the regulation of adult hippocampal neurogenesis. (1:500, R&D Systems), and β -III Tubulin (1:500, Promega); rabbit polyclonal antibodies against PCNA (1:500, Millipore) and GFP (1:5,000, Invitrogen). The following primary antibodies and dilutions were used for Western blot analysis: rabbit polyclonal ERK5 antiserum (1:1,000), rabbit polyclonal MEK5 antibody (1:500, Santa Cruz Biotech Inc.), rabbit polyclonal ERK1/2 (1:10,000, Millipore), rabbit polyclonal p-ERK5 antibody (1:1,000, Cell Signaling), and mouse monoclonal β -actin antibody (1:10,000, Sigma). Secondary antibodies were rabbit polyclonal Horse Radish Peroxidase (HRP) antibody (1:10,000, Calbiochem) and mouse monoclonal HRP antibody (1:20,000, Calbiochem).
EXPERIMENTAL PROCEDURES
BrdU and Tamoxifen administration. Mice were treated with 100 mg/kg BrdU (Sigma) by intraperitoneal (IP) injection 5 times (every 2 h for 10 h) in one day followed by sacrifice 4 weeks later to identify BrdU-retaining, adult-born cells. Tamoxifen (Sigma) was made fresh daily and dissolved in 2% glacial acetic acid in corn oil solution (Sigma). To activate Cre-mediated recombination, 5 mg of pre-warmed tamoxifen was administered orally to 10-12 week-old male mice daily for 7 d (Figure 9A 
Immunohistochemistry (IHC).
Brains were postfixed in 4% paraformaldehyde (PFA) in PBS overnight at 4°C after standard intracardial perfusion procedures. Brains were then placed in 30% (w/v) sucrose in PBS at 4°C until brains sunk and immediately frozen at -80°C. IHC was performed on 30 µm-thick coronal brain sections using a free-floating antibody staining method as described (29) .
Immunocytochemistry. Cells were fixed in PBS containing 4% PFA and 4% sucrose at room temperature for 30 min. Fixed cells were washed 3 x 5 min in PBS, 5 min in 1% SDS, and washed again 3 x 5 min in PBS. Cells were then incubated in blocking buffer consisting of 5% bovine serum albumin (BSA) in PBST (PBS + 0.1% Triton X-100) for 2 h, followed by incubation with primary antibodies overnight at 4°C. Cells were then washed 3 x 10 min in PBST, followed by incubation with secondary antibodies at 1:5,000 dilution (Alexa Fluor-488) or 1:2,000 dilution (Alexa Fluor-594) for 2 h in blocking buffer. Cells were then washed 3 x 10 min in PBST followed by a 10 min incubation in Hoechst 33342 for nuclei visualization and a final wash of 10 min in PBST prior to mounting onto slides using anti-fade Aqua Poly/Mount solution. Unless otherwise stated, all steps were carried out at room temperature.
Confocal imaging and analysis. All images were captured with an Olympus Fluoview-1000 laser scanning confocal microscope with numerical aperture (NA) 0.75, 20X lens or NA 1.3, 40X oil immersion lens. Optical Z-sections (0.5-1 µm) were collected and processed using ImageJ software (NIH). Images were uniformly adjusted for color, brightness, and contrast with Adobe Photoshop CS4 (Adobe Systems Inc).
Quantification of immunostained cells. Greater than 100 immunopositive cells per coverslip per experiment were quantified using an inverted fluorescence microscope (Leitz DMIRB, Leica) with a 40X objective (Leica) following immunocytochemistry. A modified optical fractionator method was used as an unbiased stereological method for obtaining an estimation of total cell counts per SGZ following immunohistochemistry (32) (33) (34) . The method for in vivo cellular quantification and co-localization analysis per SGZ was as described (29) .
SGZ-derived adult neural progenitor cell (aNPCs)
cultures. Primary cell cultures were prepared as described (35, 36) . Briefly, tissue samples containing the dentate gyrus were micro-dissected and enzymatically digested with 0.1% trypsin-EDTA (Gibco) for 7 min at 37°C followed by incubation with equal volume of 0.014% trypsin inhibitor (Gibco). Tissue samples were then spun down and resuspended in culture media consisting of DMEM/F12 (Gibco), 1X N2 supplement (Invitrogen), 1X B27 supplement without retinoic acid (Gibco), 100 U/mL penicillin/streptomycin (Gibco), 2 mM L-glutamine (Gibco), 2 µg/mL heparin (Sigma), 20 ng/mL EGF (EMD Chemicals), and 10 ng/mL bFGF (Millipore). Culture medium for adult neural progenitor cells always contain EGF and bFGF unless otherwise specified. Tissue was mechanically triturated and filtered through a 40 µm cell sieve and plated in petri dishes and cultured for 10-14 d until neurospheres are formed. Growth factors were replenished every 3 d during this period. Following primary passage, neurospheres were isolated, dissociated into single-cell suspension enzymatically and mechanically, and replated at low density and cultured for secondary neurosphere formation. Spheres collected from secondary passage were dissociated and plated as a monolayer culture on poly-D-lysine/laminin-(BD Biosciences) or poly-L-ornithine/fibronectin-(BD Biosciences) coated aclar coverslips (Electron Microscopy Sciences) for experiments.
Retrovirus construction and production. The ERK5 shRNA and control non-specific shRNA (shNS) retroviruses have been previously described (25) . Briefly, shNS directed towards dsRED sequence (agttccagtacggctccaa), and shERK5 directed towards murine ERK5 sequence (aa 106-111: acacttcaaacacgacaat), were subcloned into pSIE retroviral vector (37) . cDNA sequences encoding wild-type ERK5 or constitutively active MEK5 (24, 38) were subcloned into the Sal I/Xho I restriction sites within the multiple-cloning site of an oncoretroviral expression vector, which contains an IRES-GFP sequence and was described in (39) . High-titer VSV-G pseudotyped retroviral stocks were produced as described (37) .
Characterization of retroviral ERK5 or caMEK5.
NIH-3T3 cells were plated in 6-well tissue culture treated plates at 5 x 10 4 cells per well in DMEM (Gibco) containing 10% fetal bovine serum and 100 U/mL penicillin/streptomycin. Following overnight plating, protamine sulfate (Invitrogen) was added to culture media at a final concentration of 8 µg/mL and 8 µL of 1 x 10 9 infection units per mL (IU/mL) of retroviruses were added to each well and allowed to transduce cells for 24 h. Where co-transduction was required, a 1:1 ratio of retroviral ERK5 and caMEK5 were added to each well and cells transduced for 24 h. Following 24 h transduction, media was refreshed and cells were cultured for an additional 3 d before processing for Western blot analysis as described (21) .
Viral transduction of aNPCs.
For Western blot analysis of shERK5 specificity, aNPCs were plated as a monolayer culture on poly-Lornithine/fibronectin-coated, 12-well tissue culture plates at a density of 3 x 10 5 cells per well in culture media as described above. Twenty-four hours after plating, protamine sulfate was added to culture media at a final concentration of 8 µg/mL, and cells were infected with 20 µL of 1 x 10 9 IU/mL shNS and shERK5 retroviruses. Four days following retrovirus infection, cells were lysed for Western blot analysis as described (21) . For immunocytochemistry studies, aNPCs were plated as a monolayer culture on poly-D-lysine/lamininor poly-L-ornithine/fibronectin-coated aclar coverslips in 24-well plates at a density of 1 x 10 5 cells per well in culture media. Twenty-four hours after plating, protamine sulfate was added to culture media at a final concentration of 8 µg/mL and 6-8 µL of 1 x 10 9 IU/mL retroviruses were added to each well and allowed to transduce cells for 24 h. In cases where co-transduction with retrovirus and lentivirus were needed ( Figure 6 ), aNPCs were first transduced with retrovirus for 10 h followed by transduction with lentivirus for an additional 24 h at a ratio of 3:1, respectively. Following transduction, culture media was changed and cells were cultured for an additional 5 d before being processed for immunocytochemistry.
Neurotrophin treatment. For neurotrophin activation of ERK5, aNPCs were plated as a monolayer on poly-L-ornithine/fibronectin-coated 12-well plates at a density of 7 x 10 5 cells per well. Forty-eight hours after plating, cells were switched into culture medium free of EGF and bFGF overnight before treatment with BDNF (50 ng/mL, Alomone Labs) or NT3 (100 ng/mL, Millipore). For neurotrophin stimulation of aNPC neuronal differentiation, cells were plated as a monolayer on poly-L-ornithine/fibronectin-coated aclar coverslips at a density of 1 x 10 5 cells per well. One day after plating, cells were transduced with 8 µL of shNS or shERK5 retrovirus in the presence of 8 µg/mL protamine sulfate. Twenty-four hours later, the virus-containing medium was removed and cells were cultured with fresh medium for 3 d to allow retroviral expression. Cells were then incubated for 3 d in fresh medium containing 100 ng/mL NT3, or 1 µg/mL BSA as a control. Finally, EGF and bFGF were removed from the culture medium and cells were incubated for an additional 5 d in the continued presence of NT3 or BSA to allow neuronal differentiation.
To examine the effect of shERK5 on more differentiated aNPCs, cells were plated as a monolayer at a density of 1 x 10 5 cells per well on poly-L-ornithine/fibronectin-coated aclar coverslips in medium containing 50 ng/mL BDNF or 100 ng/mL NT3 for 3 d. EGF and bFGF were then removed from the culture medium and cells were incubated for an additional 3 d in the continued presence of BDNF or NT3. Cells were then transduced with shNS or shERK5 retroviruses as above and incubated for an additional 5 d in culture medium free of EGF and bFGF but in the continued presence of BDNF or NT3.
Lentiviral Neurog2 transfer construct (pRRLcPPT-CMV-Neurog2-PRE-SIN-IRES-EGFP).
Flag-Neurog2 cDNA sequence was inserted into a multiple cloning site of lentiviral transfer vector pRRL-cPPT-CMV-X-PRE-SIN-IRES-EGFP, described in (24), upstream from the internal IRES-directed marker protein eGFP (enhanced green fluorescent protein). High-titer lentiviral stocks were produced as described (24) .
NeuroD2-Luciferase reporter gene assay. Primary cortical neurons were prepared from embryonic day 15 (E15) Sprague-Dawley rats (Charles River Laboratories) and cultured in petri dishes for 5 h before transfection. Cells were transiently transfected with Nucleofector ® Transfection Reagent (Amaxa Biosystems, Inc.) as previously described (25) . Briefly, E15 cortical neurons were collected and resuspended in Rat Neural Stem Cell Nucleofector® Transfection Reagent at a density of 6 x 10 6 cells / 100 µl. For each transfection, 6 x 10 6 cells were transfected with 5 µg NeuroD2-Luc reporter, 100 ng pRL renilla-Luc reporter (Promega), 1 µg Flag-Neurog2 expression construct or pCDNA3 control plasmid, and 4 µg shERK5 retroviral plasmid or shNS control plasmid using the Amaxa Nucleofector® with A31 protocol. Immediately following Nucleofection, cells were resuspended in pre-warmed (37°C) regular culture medium and incubated at 37°C for 20 min. Cells were then resuspended in regular culture medium (Neurobasal Medium (Gibco), 2% B27 without retinoic acid, 10 ng/mL bFGF) and plated onto 12-well plates coated with poly-Dlysine/laminin. After 72 h in culture, cells from each well were lysed with 100 µl passive lysis buffer and 20 µl lysates were applied for dual luciferase assay per manufacturer's protocol (Promega).
Stereotaxic surgery. Stereotaxic procedure was performed on adult C57/BL6 male mice (8-10 weeks old, Charles River Laboratories) as described (40, 41) . Mice were anaesthetized by IP injection (21-23 µl/g body weight) of ketamine (7.0 mg/mL) and xylazine (0.44 mg/mL) dissolved in 0.9% bacteriostatic saline (Hospira, Inc.). One microliter of retrovirus (10 9 -10 10 IU/mL) was injected at a rate of 0.25 mL/min bilaterally into the dentate gyrus with the following coordinates relative to Bregma: 1.65 mm posterior, ±1.62 mm medial-lateral, 2.30 mm ventral.
Statistical analysis. All of the in vitro cell culture data were from at least two independent experiments with duplicates or triplicates each (total n ≥ 5 for each data point). In vivo cellular quantification data were from at least two independent experiments with n ≥ 12 for data in Figure 8 and n ≥ 6 for data in Figure 9 .
.m.). n.s. not significant; *, p < 0.05; **, p < 0.01; ***, p < 0.001.
RESULTS

ERK5 expression in the adult mouse brain is specific to the neurogenic regions
ERK5 expression in the adult mouse brain was examined by immunohistochemistry using an affinity-purified ERK5-specific antibody directed against the unique C-terminal tail of ERK5 protein (18) . We found no ERK5 protein in cornu ammonis (CA) 1 and CA3 regions of the hippocampal formation, or most other areas of adult brain including the cortex and striatum (Fig.  1) , consistent with other reports (26) . However, ERK5 protein was specifically expressed in the SVZ (Fig. 1A, B) and along the SGZ of the dentate gyrus in the hippocampal formation (Fig.  1C, D) . Specifically, ERK5 was expressed in SGZ cells co-labeled with markers for stem/progenitor cells (Sox2, GFAP), proliferation (BrdU, PCNA), transiently amplifying progenitors and/or newborn neurons (PSA-NCAM, DCX, and NeuroD) ( Fig.  2A-S, and X) . Some of the ERK5 + cells were also positive for both GFAP and Sox2, suggesting ERK5 expression in radial glia-like stem cells ( Fig. 2A-G, and X) (Fig. 2X) . Finally, almost 80% of ERK5 + cells in the SGZ were also PSA-NCAM + and DCX + . The specific expression of ERK5 in adult neurogenic regions is quite unique and interesting, and suggests an important function for ERK5 in regulating adult neurogenesis, particularly for the regulation of the cell fate of transiently amplifying progenitors and/or newborn neuron populations.
ERK5 signaling contributes to neuronal differentiation of SGZ-derived aNPCs in culture
SGZ-derived aNPCs were prepared from the dentate gyrus of 8-10 week-old adult mice as described (35, 42) . Western analysis confirmed ERK5 expression in these cells (Supplemental Fig.  1 ). When aNPCs were allowed to differentiate in culture by removing bFGF and EGF from the culture media, retroviral infection of ERK5 shRNA, which specifically suppresses the expression of endogenous ERK5 but not the closely related ERK1/2 ((25) and Supplemental Fig. 1) , significantly decreased the number of cells expressing β-III tubulin, a marker for newborn neurons (Fig. 3A-E) . Concomitantly, shRNA to ERK5 increased the number of cells expressing markers for stem/progenitor cells (Sox2, Nestin) and proliferation (PCNA) (Fig. 3F-N) . However, it did not promote glial differentiation (33% vs. 26% cells co-expressed glial marker GFAP in shNS or shERK5 infected cells, respectively, p > 0.5).
To activate endogenous ERK5 signaling, wild type (wt) ERK5 or caMEK5 were subcloned into a retroviral expression vector, upstream from an IRES-directed marker protein eGFP. Retroviral transduction of caMEK5 specifically activated endogenous ERK5 (Fig. 4A) and was sufficient to decrease the number of cells positive for Sox2, Nestin, and PCNA, while simultaneously increasing the pool of β-III tubulin + neurons even in the presence of mitogens bFGF and EGF (Fig.  4B-O) . These data suggest a critical role for ERK5 in promoting neurogenesis in cultured aNPCs. Furthermore, aNPCs that did not differentiate into neurons upon ERK5 inhibition remained in the proliferating and stem/progenitor stage rather than undergoing precocious glial differentiation (data not shown).
Neurog2 may be a downstream target of ERK5 in adult neurogenesis
To elucidate downstream mechanisms mediating the neurogenic effect of ERK5 in SGZ cells, we investigated if ERK5 regulates the transcriptional activity of Neurog2, a basic helixloop-helix (bHLH) transcription factor expressed in SGZ progenitors (43, 44) . A dual luciferase reporter assay was performed to measure Neurog2-stimulated transcription initiated from the NeuroD2-Luc reporter (25) . Expression of Neurog2 alone stimulated NeuroD2-Luc activity 4-fold; this transcription was suppressed by cotransfection of shERK5 (Fig. 5) . Neurog2 is essential for neurogenesis in the dentate gyrus during development (45) ; however, its function in adult hippocampal neurogenesis has not been elucidated. Consequently, we examined if ectopic expression of Neurog2 is sufficient to promote neuronal differentiation of SGZ cells and if this is regulated by ERK5 signaling. SGZ-derived aNPCs were infected with lentiviruses expressing Neurog2-IRES-GFP; lentiviral-GFP was used as a control. Expression of Neurog2 was sufficient to increase the number of β-III tubulin + neurons even in the presence of bFGF and EGF (Fig. 6A-I ). In contrast, Neurog2 decreased the number of Sox2 + neural stem cells. Significantly, co-infection of shERK5 retroviruses blocked the effect of Neurog2 on neuronal differentiation (Fig. 6J-R) . These data suggest that Neurog2 exhibits proneural activity in SGZ cells and may act as a downstream target of ERK5 during adult hippocampal neurogenesis.
NT3 promotes neuronal differentiation of SGZderived aNPCs in an ERK5-dependent manner
To begin to identify upstream activators of ERK5 signaling that regulate SGZ adult neurogenesis, we determined if ERK5 is activated by neurotrophins in aNPCs. Treatment with either BDNF or NT3 induced phosphorylation of ERK5 (p-ERK5) in SGZ-derived aNPCs (Fig. 7A) , indicative of ERK5 activation. NT3 also increased the number of β -III tubulin + neurons (Fig. 7B ), suggesting that NT3 stimulates neuronal differentiation of these cells. Significantly, the effect of NT3 on neuronal differentiation was completely blocked by shERK5. Additionally, shERK5 inhibited neuronal differentiation when aNPCs were pre-treated with BDNF or NT3 to prime neuronal differentiation (Supplemental Fig.  2 ). These data suggest that NT3 stimulates hippocampal neurogenesis by activating the ERK5 signaling pathway.
Activation of endogenous ERK5 promotes SGZ neurogenesis in vivo
To investigate if activation of ERK5 promotes adult neurogenesis in vivo, we delivered retroviruses encoding caMEK5-IRES-eGFP and/or wtERK5-IRES-eGFP as well as the vector-control retrovirus to the dentate gyrus of adult mice using a stereotaxic surgery protocol (41) . Two weeks following stereotaxic surgery, mice were sacrificed and their brains processed for immunohistochemistry to identify GFP + infected cells and cells expressing NeuroD (Fig. 8A-I ). Retroviral expression of caMEK5 alone or together with wtERK5 in vivo significantly increased the number of NeuroD + cells in the retrovirus-infected cell population (GFP + ) along the SGZ (Fig. 8J) (Fig. 9A) . In contrast, there were abundant YFP + cells along the SGZ of tamoxifen treated mouse brains (Fig. 9B) + cells in the SGZ of ERK5 icKO mice by 75% compared to control animals ( Fig. 9C-E) . There was no difference in the total number of BrdU + cells in the dentate gyrus of control vs. ERK5 icKO mice (Fig.  9F) . However, deletion of the erk5 gene reduced the number of adult-born, mature neurons (NeuN and BrdU double-positive cells among total BrdU + population) in the dentate gyrus (Fig. 9K-M) . Concomitantly, there was an increase in the number of BrdU + cells co-labeled with DCX or Calretinin, a marker for immature granular neurons (Fig. 9G-J, M) . This suggests that although ERK5 deletion does not change the total number of adult-born cells in the SGZ, it reduces the total number of adult-born mature neurons by delaying neuronal differentiation.
DISCUSSION
New neurons are continuously born in the adult dentate gyrus of the hippocampus. Although these adult-born neurons have been characterized at the cellular level, signaling mechanisms regulating adult hippocampal neurogenesis are not well defined. The goal of this study was to investigate the role of ERK5 MAP kinase in the regulation of adult hippocampal neurogenesis.
Despite its abundant presence in the developing brain, ERK5 expression declines as the brain matures (21) and it is generally thought to be absent in the adult brain ((26) and Allen Brain Atlas). We report here, that although ERK5 expression is generally absent in most areas of adult brain, it is prominently expressed in the two neurogenic regions. The expression of ERK5 MAP kinase is quite unique and distinct from other signaling molecules implicated in adult neurogenesis, such as NeuroD, sonic hedgehog, Wnt, PI3K-Akt and BDNF, which are more widely expressed in the brain (46) (47) (48) (49) (50) (51) (52) (53) (54) . It also suggests that ERK5 may be critical in the regulation of adult neurogenesis. Indeed, shRNA knockdown of ERK5 in cultured aNPCs or conditional deletion of the erk5 gene specifically in the neurogenic regions of the adult mouse brain reduces neurogenesis in vitro and in vivo, respectively. By contrast, ectopic activation of endogenous ERK5 signaling via expression of caMEK5 promotes neurogenesis in cultured aNPCs as well as in the dentate gyrus of mouse brains. These data suggest that ERK5 signaling is an important regulator of adult neurogenesis in SGZ cells both in vitro and in vivo.
Although ERK5 expression in the SGZ of the adult mouse brain is found in cells expressing markers for neural stem/progenitor cells, actively proliferating cells, transiently amplifying progenitors and/or newborn neurons, the majority of ERK5-positive cells express markers for transiently amplifying progenitors and/or newborn neurons. These data indicate that ERK5 may primarily regulate adult hippocampal neurogenesis through its action on these cell populations, including affecting neuronal differentiation and maturation. Indeed, shRNA knockdown of ERK5 in cultured aNPCs reduces the number of newborn neurons while simultaneously increasing the number of proliferating cells and progenitor cells. These data, coupled with the fact that shERK5 did not increase the number of GFAP + astrocytes suggest that inhibition of ERK5 attenuates neuronal differentiation without causing precocious glial differentiation. Using transgenic mouse technology, we conditionally deleted the erk5 gene specifically in Nestin-expressing neural stem cells in the adult brain. Although this inducible and conditional gene targeting of erk5 did not affect the total number of adult-born cells (BrdU + ) in the dentate gyrus in vivo, it reduced the number of adult-born mature neurons (BrdU + and NeuN + ) while concomitantly increasing the number of cells expressing immature neuron markers DCX and Calretinin. These data suggest that loss of ERK5 causes a delay in the normal progression of neuronal differentiation and maturation during adult neurogenesis.
Neural progenitors in the SGZ express a cascade of transcription factors including Neurog2 (43, 44) . Neurog2 belongs to a family of bHLH transcription factors that also includes Neurog1 and are critical for neuronal fate specification during development (55) . Neurog2 is essential for neurogenesis in the dentate gyrus during development (45) . However, its role in adult SGZ neurogenesis has not been demonstrated. Here we report that ectopic expression of Neurog2 is sufficient to promote neuronal differentiation of SGZ-derived aNPCs in culture, providing evidence that Neurog2 may confer pro-neural activity during adult hippocampal neurogenesis. We previously reported that ERK5 regulates both the transcriptional and pro-neural activities of Neurog1 during cortical development (25) . This prompted us to investigate if ERK5 regulates adult hippocampal neurogenesis through Neurog2. Indeed, shRNA suppression of ERK5 signaling inhibited both the transcriptional and pro-neural activities of Neurog2 in cultured SGZ-derived aNPCs. Although it is possible that ERK5 could act downstream, in parallel, or upstream of Neurog2, the fact that ERK5 activity is required for Neurog2-stimulated transcription favors the interpretation that ERK5 is an upstream regulator of Neurog2.
What are the upstream extracellular signals that ERK5 responds to in regulating adult hippocampal neurogenesis? We have published evidence that ERK5 is activated by neurotrophins including brain-derived neurotrophic factor (BDNF) and NT3 in neurons (18 5) , or 100 ng/mL NT3 (lanes 6-9) for indicated times. Total ERK5 (T-ERK5) was used as a loading control. (B) NT3 stimulates neuronal differentiation of SGZ-derived aNPCs through a process that requires ERK5. SGZ-derived aNPCs were infected with retroviruses encoding a non-specific control (shNS) or shERK5. Cells were then incubated in EGF/bFGF-free medium and treated with NT3 (100 ng/ml) for 5 d to induce neuronal differentiation. Cells treated with BSA (1 µg/ml) were used as a control. 
